Caliway Biopharmaceuticals (CLBPF) Q3 2025 Earnings

8AugConfirmed
Q3 2025
-0.01
-0.01
-0
-0

Details

Expected EPS
-0.004560171
Actual EPS
-0.00548592
Surprise EPS
-0
Surprise Percent
+20.3%

Description

Caliway Biopharmaceuticals (CLBPF) has reported earnings of -0.00548592 per share for Q3 2025.

0 Comments

Share your thoughts